高级检索
当前位置: 首页 > 详情页

Risk-predicted dual nomograms consisting of clinical and ultrasound factors for downgrading BI-RADS category 4a breast lesions - A multiple centre study

文献详情

资源类型:
WOS体系:
Pubmed体系:

收录情况: ◇ SCIE

单位: [1]Chinese Acad Med Sci & Peking Union Med Coll, Peking Union Med Coll Hosp, Dept Ultrasound, 1 Shuai Fu Yuan, Beijing 100730, Peoples R China [2]Harbin Med Univ, Affiliated Hosp 2, Dept Ultrasound, Harbin 150086, Peoples R China [3]Chongqing Med Univ, Affiliated Hosp 2, Dept Ultrasound, Chongqing 400010, Peoples R China [4]Chongqing Key Lab Ultrasound Mol Imaging, Chongqing 400010, Peoples R China [5]China Med Univ, Shengjing Hosp, Dept Ultrasound, Shenyang 110004, Peoples R China [6]Fudan Univ, Shanghai Canc Ctr, Dept Med Ultrasound, Shanghai 200032, Peoples R China [7]Fudan Univ, Shanghai Med Coll, Dept Oncol, Shanghai 200032, Peoples R China [8]Henan Prov Peoples Hosp, Dept Ultrasonog, Zhengzhou 450003, Peoples R China [9]Shanxi Med Univ, Dayi Hosp, Shanxi Acad Med Sci, Dept Ultrasound, Taiyuan 030032, Peoples R China [10]Huazhong Univ Sci & Technol, Tongji Hosp, Tongji Med Coll, Dept Med Ultrasound, Wuhan 430030, Peoples R China [11]Jilin Univ, China Japan Union Hosp, Dept Ultrasound, Changchun 130033, Peoples R China [12]Sun Yat Sen Univ, Sun Yat Sen Mem Hosp, Dept Ultrasound, Guangzhou 510120, Peoples R China [13]Guangxi Med Univ, Affiliated Hosp 1, Dept Ultrasonog, Nanning 530021, Peoples R China [14]Xi An Jiao Tong Univ, Affiliated Hosp 2, Sch Med, Dept Med Ultrasound, Xian 710004, Peoples R China [15]Fujian Med Univ, Fujian Inst Ultrasound Med, Dept Ultrasound, Union Hosp, Fuzhou 350001, Peoples R China [16]Shanghai Jiao Tong Univ, Ruijin Hosp, Sch Med, Dept Ultrasound, Shanghai 200025, Peoples R China [17]Wuhan Univ, Renmin Hosp, Dept Ultrasonog, Wuhan 430060, Peoples R China [18]Shandong Univ, Qilu Hosp, Dept Ultrasound, Jinan 250012, Peoples R China [19]Cent South Univ, Xiangya Hosp 3, Dept Ultrasound, Changsha 410013, Peoples R China [20]Nanchang Univ, Affiliated Hosp 2, Dept Ultrasound, Nanchang, Jiangxi, Peoples R China [21]Shanghai Jiao Tong Univ, Tongren Hosp, Sch Med, Dept Ultrasound Med, Shanghai 200336, Peoples R China [22]Guizhou Med Univ, Dept Ultrasonog, Affiliated Hosp, Guiyang 550004, Peoples R China [23]Jinan Univ, Shenzhen Peoples Hosp, Clin Med Coll 2, Dept Ultrasound, Shenzhen 518020, Peoples R China [24]Shanxi Med Univ, Hosp 1, Dept Ultrasound, Taiyuan 030001, Peoples R China [25]Dalian Med Univ, Hosp 2, Dept Ultrasound, Dalian 116027, Peoples R China [26]Qingdao Univ, Affiliated Hosp, Dept Ultrasound, Qingdao 266003, Peoples R China
出处:
ISSN:

关键词: Breast cancer ultrasonography risk factors elastography Nomogram

摘要:
Purpose: To develop and to validate a risk-predicted nomogram for downgrading Breast Imaging Reporting and Data System (BI-RADS) category 4a breast lesions. Patients and Methods: We enrolled 680 patients with breast lesions that were diagnosed as BI-RADS category 4a by conventional ultrasound from December 2018 to June 2019. All 4a lesions were randomly divided into development and validation groups at the ratio of 3:1. In the development group consisting of 499 cases, the multiple clinical and ultrasound predicted factors were extracted, and dual-predicted nomograms were constructed by multivariable logistic regression analysis, named clinical nomogram and ultrasound nomogram, respectively. Patients were twice classified as either "high risk" or "low risk" in the two nomograms. The performance of these dual nomograms was assessed by an independent validation group of 181 cases. Receiver Operating Characteristic (ROC) curve and diagnostic value were calculated to evaluate the applicability of the new model. Results: After multiple logistic regression analysis, the clinical nomogram included 2 predictors: age and the first-degree family members with breast cancer. The area under the curve (AUC) value for the clinical nomogram was 0.661 and 0.712 for the development and validation groups, respectively. The ultrasound nomogram included 3 independent predictors (margins, calcification and strain ratio), and the AUC value in this nomogram was 0.782 and 0.747 in the development and validation groups, respectively. In the development group of 499 patients, approximately 50.90% (254/499) of patients were twice classified "low risk", with a malignancy rate of 1.18%. In the validation group of 181 patients, approximately 47.51% (86/181) of patients had been twice classified as "low risk", with a malignancy rate of 1.16%. Conclusions: A dual-predicted nomogram incorporating clinical factors and imaging characteristics is an applicable model for downgrading the low-risk lesions in BI-RADS category 4a and shows good stability and accuracy, which is useful for decreasing the rate of invasive examinations and surgery.

基金:
语种:
被引次数:
WOS:
PubmedID:
中科院(CAS)分区:
出版当年[2020]版:
大类 | 3 区 医学
小类 | 3 区 肿瘤学
最新[2025]版:
大类 | 3 区 医学
小类 | 4 区 肿瘤学
JCR分区:
出版当年[2019]版:
Q2 ONCOLOGY
最新[2023]版:
Q2 ONCOLOGY

影响因子: 最新[2023版] 最新五年平均 出版当年[2019版] 出版当年五年平均 出版前一年[2018版] 出版后一年[2020版]

第一作者:
第一作者单位: [1]Chinese Acad Med Sci & Peking Union Med Coll, Peking Union Med Coll Hosp, Dept Ultrasound, 1 Shuai Fu Yuan, Beijing 100730, Peoples R China
通讯作者:
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:590 今日访问量:1 总访问量:442 更新日期:2025-06-01 建议使用谷歌、火狐浏览器 常见问题

版权所有:重庆聚合科技有限公司 渝ICP备12007440号-3 地址:重庆市两江新区泰山大道西段8号坤恩国际商务中心16层(401121)